BTG plc Stock Rating Reaffirmed by Investec (BTG)
BTG plc (LON:BTG)‘s stock had its “buy” rating restated by research analysts at Investec in a report released on Tuesday. They currently have a GBX 723 ($12.16) target price on the stock. Investec’s price objective indicates a potential upside of 37.71% from the stock’s previous close.
BTG plc (LON:BTG) opened at 515.00 on Tuesday. BTG plc has a 52 week low of GBX 323.10 and a 52 week high of GBX 624.00. The stock’s 50-day moving average is GBX 537.6 and its 200-day moving average is GBX 552.0.
A number of other firms have also recently commented on BTG. Analysts at N+1 Singer reiterated a “sell” rating on shares of BTG plc in a research note on Tuesday. Separately, analysts at FinnCap reiterated a “sell” rating on shares of BTG plc in a research note on Tuesday. Finally, analysts at Panmure Gordon reiterated a “buy” rating on shares of BTG plc in a research note on Friday. They now have a GBX 670 ($11.27) price target on the stock. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the company. BTG plc has an average rating of “Hold” and a consensus price target of GBX 565.14 ($9.51).
BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.